Abstract
Somatostatin receptor scintigraphy is a new, very sensitive procedure for detecting receptor-positive neuroendocrine tumors. Radiolabeled somatostatin analogues are selectively taken up after intravenous administration by tissue carrying somatostatin receptors and, as with the skeletal scintiscan, permit a whole-body visualization of receptor-positive tumors and metastases. Somatostatin receptor scintigraphy shows an overall sensitivity of about 84% for neuroendocrine gastroenteropancreatic tumors. This kind of scintigraphy should be applied in primary tumor localization, staging, and course control in a confirmed or highly probable neuroendocrine gastroenteropancreatic tumor. Furthermore, the use of a gamma probe for intraoperative tumor localization is demonstrated. Therapy with radioactively marked somatostatin analogues should be possible because of the highly selective tumor uptake. The development of an optimal tracer is the subject of current research.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ahlman H, Wängberg B, Tisell LE, Nilsson O, Fjälling M, Forssell-Aronsson E (1994) Clinical efficacy of octreotide scintigraphy in patients with midgut carcinoid tumors and evaluation of intraoperative scintillation detection. Br J Surg 81: 1144–1149
Amherdt M, Patel YC, Orci L (1987) Selective binding of somatostatin-14 and somatostatin-28 to islet cells revealed by quantitative electron microscopic autoradiography. J Clin Invest 80: 1455–1458
Arnold R, Neuhaus C, Trautmann ME (1992) Therapie endokriner gastroenteropankreatischer Tumoren mit dem Somatostatin-Analogon Octreotid. Dtsch Med Wochenschr 117: 1067–1071
Bakker WH, Albert R, Bruns C, Breeman WAP, Hofland LJ, Marbach P, Pless J, Pralet D, Stolz B, Koper JW, Lamberts SWJ, Visser TJ, Krenning EP (1991a) [In-111-DTPA-D-Phe1]-Octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis, radiolabeling and in vitro validation. Life Sci 49:1583–1591
Bakker WH, Krenning EP, Breeman WAP, Kooij PPM, Reubi JC, Koper JW, de Jong M, Lameris JS, Visser TJ, Lamberts SWJ (1991b) In vivo use of a radioiodinated somatostatin analogue: dynamics, metabolism and binding to somatostatin receptor-positive tumors in man. J Nucl Med 32: 1184–1189
Bakker WH, Krenning EP, Breeman WAP, Koper JW, Kooij PPM, Reubi JC, Klijn JGM, Visser TJ, Docter R, Lamberts SWJ (1990) Receptor scintigraphy with a radioiodinated somatostatin analogue: radiolabeling, purification, biological activity and in vivo applications in animals. J Nucl Med 31: 1501–1509
Bauer W, Briner U, Doepfner W, Haller R, Huguenin R, Marbach P, Peteher TJ, Pless J (1982) SMS 201–995: a very potent and selective octapeptide analogue of somatostatin with prolonged action. Life Sci 31: 1133–1140
Colton CL, Hardy JG (1983) Evaluation of a sterilizable radiation probe as an aid to the surgical treatment of osteoid-osteoma. J Bone Joint Surg (BR) 65: 1019–1022
Dop F-J (1994) The European multicentre clinical trial group on GEP neuroendocrine tumors. J Nucl Med 35: 96 P
Dörr U, Räth U, Schürmann G, Höring E, Bach D, Wurm K, Scholz M, Adrian HJ, Bihl H (1993) Somatostatin-Rezeptor-Szintigraphie. Ein neues bildgebendes Verfahren zum spezifischen Nachweis von Dünndarmkarzinoiden. Fortschr Röntgenstr 158: 67–73
Draznih B, Sherman N, Sussman KE, Dahl R, Vatter R (1985) Internalization and cellular processing of somatostatin in primary culture of rat anterior pituitary cells. Endocrinology 117: 960
Enjalbert A, Tapia-Arancibia L, Rieutort M et al (1982) Somatostatin receptors on rat anterior pituitary membranes. Endocrinology 110: 1634–1640
Faiss S, Scherübl H, Bäder M, Fett U, Koppenhagen K, Wiedenmann B, Riecken EO (1994) Bedeutung falsch-positiver Befunde in der Diagnostik neuroendokriner Tumoren des gastroenteropankreatischen Systems. Z Gastroenterol 32: 243–246
Fischmann AJ, Babick JW, Strauss HW (1993) A ticket to ride: peptide radiopharmaceuticals. J Nucl Med 34: 2253–2263
Gadiot G, de Kerviler E, Le Guludec D, Camhaji B, Sobhani I, Ruszniewski P, Mignon M (1993) In patients with the Zollinger-Ellison syndrome (ZES) the main interest of somatostatin receptor scintigraphy ( SRS) is to detect previously unknown metastases. Gastroenterology 104: A298
Heiman ML, Murphy WA, Coy DH (1987) Differential binding of somatostatin agonists to somatostatin receptors in brain and adenohypophysis. Neuroendocrinology 45: 429
Heitz P, Klöppel G (1987) Endokrine Tumoren des Pankreas and des Duodenum. Verh Dtsch Ges Pathol 71: 202–221
Höring E, Räth U, Rucker S, von Gaisberg U, Meincke J, Walendzik J, Dörr U, Bihl H (1994) Somatostatinrezeptor-Szintigraphie in der Primärdiagnostik and Nachsorge bei Gastrinomen. Dtsch Med Wochenschr 119: 367–374
Joseph K, Stapp J, Reinecke J, Skamel HJ, Höffken H, Neuhaus C, Lenze H, Trautmann ME, Arnold R (1993) Receptor scintigraphy with 111In-pentetreotide for endocrine gastroenteropancreatic tumors. Hormone Metab Res 27 [Suppl]: 28–35
Kirchner B, Hillman A, Lottes G, Sciuk J, Bartenstein P, Winkelmann W, Schober O (1993) Intraoperative, probeguided curettage of osteid osteoma. Eur J Nucl Med 20: 609–613
Kluxen F, Bruns C, Lübbert H (1992) Expression cloning of a rat brain somatostatin receptor eDNA. Proc Natl Acad Sci U S A 89: 4618–4622
Krenning EP, Bakker WH, Breeman WAP, Koper JW, Kooij PPM, Ausema L, Lameris JS, Lamberts SWJ (1989) Localization of endocrine related tumors with radioiodinated analogue of somatostatin. Lancet 1: 242–245
Krenning EP, Bakker WH, Kooij PPM, Breeman WAP, Oei HY, de Jong M, Reubi J-C, Visser TJ, Bruns C, Kwekkeboom DJ, Reijs AEM, van Hagen PM, Koper JW, Lamberts SWJ (1992a) Somatostatin receptor scintigraphy with Indium-111DTPA-D-Phe-1-octreotide in man: metabolism, dosimetry and comparison with Iodine-123-Tyr-3-octreotide. J Nucl Med 33: 652–658
Krenning EP, Kwekkeboom DJ, Oei HY, Reubi JC, van Hagen PM, Kooij PPM, Reijs AEM, Lamberts SWJ (1992b) Somatostatin receptor imaging of endocrine gastrointestinal tumors. Schweiz Med Wochenschr 122: 634–637
Krenning EP, Kwekkeboom DJ, Reubi J-C, van Hagen PM, van Eijck CHJ, Oei HY, Lambers SWJ (1993) 111In-Octreotide scintigraphy in oncology. Digestion 54 [Suppl 1] 11:84–87
Kwekkeboom DJ, Krenning EP, Bakker WH, Oei HY, Kooij PPM, Lamberts SWJ (1993) Somatostatin analogue scintigraphy in carcinoid tumours. Eur J Nucl Med 20: 283–292
Lamberts SWJ, Bakker WH, Reubi J-C, Krenning EP (1990a) Somatostatin-receptor imaging in the localization of endocrine tumors. N Engl J Med 232: 1246
Lamberts SWJ, Hofland LJ, van Koetsveld PM, Reubi J-C, Bruining HA, Bakker WH, Krenning EP (1990b) Parallel in vivo and in vitro detection of functional somatostatin receptors in human endocrine pancreatic tumors: consequences with regard to diagnosis, localization and therapy. J Clin Endocrinol Metab 71: 566
Lamberts SWJ, Krenning EP, Reubi J-C (1991) The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocr Rev 12: 450–482
Markstein R, Stoeckli KA, Reubi J-C (1989) Differential effects of somatostatin on adenylate cyclase as functional correlates for different brain somatostatin receptor subpopulations. Neurosci Lett 104: 13
Morel G, Pelletier G, Heisler S (1986) Internalization and subcellular distribution of radiolabeled somatostatin-28 in mouse anterior pituitary tumor cells. Endocrinology 119: 1972
O’Caroll AM, Lolait SJ, König M, Mahan LC (1992) Molecular cloning and expression of a pituitary somatostatin receptor with preferential affinity for somatostatin-28. Mol Pharmacol 42: 939–946
Patel YC, Murthy KK, Escher EE, Banville D, Spiess J, Srikant CB (1990) Mechanism of action of somatostatin: an overview of receptor function and studies of the molecular characterization and purification of somatostatin receptor proteins. Metabolism 39: 63–69
Pauwels S, Jamar F, Leners N, Fiasse R (1992) Efficacy of 111In-pentetreotide scintigraphy in endocrine gastroentero-pancreatic ( GEP) tumors. Gastroenterology 102: A387
Perkins A (1993) Perioperative nuclear medicine. Editorial. Eur J Nucl Med 20: 573–575
Reichlin, S (1983) Somatostatin. N Engl J Med 309:1495–1501, 1556–1563
Reubi J-C (1984) Evidence of two somatostatin-14 receptor types in rat brain cortex. Neurosci Lett 49: 259
Reubi J-C, Landolt AM (1984) High density of somatostatin receptors in pituitary tumors from acromegalic patients. J Clin Endocrinol Metab 59: 1148–1151
Reubi J-C, Maurer R (1985) Antoradiographic mapping of somatostatin receptors in the rat central nervous system and pituitary. Neuroscience 15: 1183–1193
Reubi J-C, Perrin M, Rivier J et al (1981) High affinity binding sites for a somatostatin28 analog in rat brain. Life Sci 28: 2191–2198
Reubi J-C, Häcki WH, Lamberts SWJ (1987a) Hormone-producing gastrointestinal tumors contain a high density of somatostatin receptors. J Clin Endocrinol Metab 65: 1127–1134
Reubi J-C, Probst A, Cortes R, Palacios JM (1987b) Distinct topographical localisation of two somatostatin receptor subpopulations in the human cortex. Brain Res 406: 391
Reubi J-C, Krenning E, Lamberts SWJ, Kvols L (1990a) Somatostatin receptors in malignant tissues. J Steroid Biochem Mol Biol 37: 1073–1077
Reubi J-C, Kvols L, Krenning E, Lamberts SWJ (1990b) Distribution of somatostatin receptors in normal and tumor tissue. Metabolism 39 [Suppl 2]: 78–81
Reubi J-C, Kvols LK, Waser B, Nagorney DM, Heitz PU, Charboneau JW, Reading CC, Moertel CG (1990c) Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas. Cancer Res 50: 5960
Reubi J-C, Maurer R, von Werder K, Torhorst J, Klijn JGM, Lamberts SWJ (1990d) Somatostatin receptors in human endocrine tumors. Cancer Res 47: 551–558
Rohrer L, Raulf F, Bruns C, Buettner R, Hofstaedter F, Schüle R (1993) Cloning and characterization of a fourth human somatostatin receptor. Proc Natl Acad Sci U S A 90: 4196–4200
Sardi A, Workman M, Mojzisik C, Hinkle G, Nieroda C, Martin EW (1989) Intra-abdominal recurrence of colorectal cancer detected by radioimmunoguided surgery (RIGS system). Arch Surg 124: 55–59
Scherübl H, Bäder M, Fett U, Hamm B, Schmidt-Gayk R, Koppenhagen K, Dop F-J, Riecken EO, Wiedenmann B (1993) Somatostatin-receptor imaging of neuroendocrine gastroenteropancreatic tumors. A new, diagnostically relevant procedure. Gastroenterology 105: 1705–1709
Schönbrunn A, Tashjian A (1978) Characterization of functional receptors for somatostatin in rat pituitary cells in culture. J Biol Chem 253: 6483
Selverstone B, Sweet WH, Robinson CV (1949) The clinical use of radioactive phosphorous in the surgery of brain tumors. Ann Surg 130: 643–651
Sreedharan SP, Kodama KT, Peterson KE, Goetzl EJ (1989) Distinct subsets of somatostatin receptors on cultured human lymphocytes. J Biol Chem 264: 949–953
Srikant CB, Patel YC (1981) Receptor binding of somatostatin-28 is tissue specific. Nature 294: 259–260
Srikant CB, Patel YC (1986) Somatostatin receptors on rat pancreatic acinar cells. Pharmacological and structural characterization and demonstration of down regulation in streptozotocin diabetes. J Biol Chem 261: 7690–7696
Srikant CB, Patel YC (1987) Somatostatin receptor: evidence for structural and functional heterogeneity. In: Reichlin S (ed) Somatostatin, basic and clinical aspects. Plenum, New York, pp 89–102
Stefanini P, Carboni M, Patrassi N, Basoli A (1974) Beta-islet tumors of the pancreas: results of a study on 1067 cases. Surgery 75: 597
Van Noorden S, Polak JM, Pearse AGE (1977) Single cellular origin of somatostatin and calcitonin in the rat thyroid gland. Histochemistry 53: 243–247
Viguerie N, Tahiri-Jouti N, Esteve JP et al (1988) Fuctional somatostatin receptors on a rat pancreatic acinar cell line. Am J Physiol 255: G113 - G120
Wang HL, Bogen C, Reisine T, Dichter M (1989) Somatostatin-14 and somatostatin-28 induce opposite effects on potassium currents in rat neocortical neurons. Proc Natl Acad Sci U S A 86: 16
Weckbecker G, Raulf F, Stolz B, Bruns C (1993) Somatostatin analogs for diagnosis and treatment of cancer. Pharmacol Ther 60: 245–264
Wiedenmann B, Gregor M (1991) Empfehlungen zur Diagnostik and Therapie von Karzinoiden ( Neuroendokrinen epithelialen Tumoren) im Raum Berlin. Berl Arztebl 104: 182–183
Woolfenden JM, Barber BH (1989) Radiation detector probes for tumor localization using tumor-seeking radioactive tracers. Am J Roentgenol 153: 35–39
Yamada Y, Ito S, Matsubara Y, Kobayashi S (1977) Immunohistochemical demonstration of somatostatin-containing cells in the human, dog and rat thyroids. Tohoku J Exp Med 122: 87–92
Yamada Y, Post SR, Wang K, Tager HS, Bell GI, Seino S (1992a) Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract and kidney. Proc Natl Acad Sci U S A 89: 251–255
Yamada Y, Reisine T, Law SF, Ihara Y, Kubota A, Kagimoto S, Seino M, Seino Y, Bell GI, Seino S (1992b) Somatostatin receptors, an expanding gene family: cloning and functional characterization of human SSTR3, a protein coupled to adenylyl cyclase. Mol Endocrinol 6: 2136–2142
Zimmer T, Ziegler K, Bäder M, Fett U, Hamm B, Riecken E-O, Wiedenmann B (1994) Localisation of neuroendocrine tumors of the upper gastrointestinal tract. Gut 35: 471–475
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Bäder, M., Koppenhagen, K. (1996). Somatostatin Receptor Scintigraphy in the Diagnosis of Neuroendocrine Gastroenteropancreatic Tumors. In: Kreuser, ED., Schlag, P.M. (eds) New Perspectives in Molecular and Clinical Management of Gastrointestinal Tumors. Recent Results in Cancer Research, vol 142. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-80035-1_10
Download citation
DOI: https://doi.org/10.1007/978-3-642-80035-1_10
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-80037-5
Online ISBN: 978-3-642-80035-1
eBook Packages: Springer Book Archive